What You Should Know:
– Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round.
– The Series A round was…
Continue Reading
Lenus Health, a supplier of predictive AI solutions, will roll out its heart failure diagnostic tool at Fleetwood Community Diagnostics Centre, part of the Blackpool Teaching Hospitals NHS Foundation Trust and the Lancashire and…
Continue Reading
What You Should Know:
– Samsung’s Galaxy Watch has received De Novo authorization from the US Food and Drug Administration (FDA) for its sleep apnea detection feature.
– This marks a significant step forward in wearable…
Continue Reading
Background: Many patients with chronic heart failure (HF) experience a reduced health status, leading to readmission after hospitalization despite receiving conventional care. Telemonitoring approaches aim to improve the early detection of HF decompensations and…
Continue Reading
Discover how the FDA-cleared Vivio System by Ventric Health is reshaping heart failure diagnosis and management. With advanced algorithms for noninvasive diagnosis, this innovative cardiac device brings timely interventions to home and outpatient settings….
Continue Reading
Heart failure affects 6.5 million people in the U.S., with an additional 550,000 newly diagnosed each year. Heart failure hospitalizations are a leading cause of admissions for those 65 and older, totaling hundreds of…
Continue Reading
By Anuja Vaidya
January 19, 2024 – A team providing palliative care via audio-only telehealth helped improve the quality of life for adults with chronic conditions like chronic obstructive pulmonary disease (COPD), heart failure, and interstitial…
Continue Reading
The following is a guest article by Oakkar Oakkar, Co-Founder and CEO at Keona Health
Imagine a tool that puts your health information right at your fingertips. That’s what patient portals promise – a simple,…
Assessment of left ventricular diastolic function plays a major role in the diagnosis and prognosis of cardiac diseases, including heart failure with preserved ejection fraction. We aimed to develop an artificial intelligence (AI)-enabled electrocardiogram…
Continue Reading
Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million, with an additional payment of $55 million to fund the platform until the acquisition…
Continue Reading
